USE OF INJECTABLE FORMS OF HYALURONIC ACID AND PLATELET RICH FIBRIN IN THE TREATMENT OF GUM LOSS IN BETWEEN TWO TEETH

Not yet recruiting

• Conditions: Chronic periodontitis,

• Registration Number: CTRI/2020/12/029924
• Lead Sponsor: Institute of Dental Studies and Technologies

Brief Summary

This study will be conducted and compiled by Dr. Aneesha Gupta, Dr.Komal Puri, Dr.Manish Khatri, Dr.Mansi Bansal, Dr. Sujata Masamatti, Dr.Rehan Khan at Department Of Periodontology, Institute of Dental Studies and Technologies, Kadrabad, Modinagar, Uttar Pradesh, India

The study is a randomized control trial for comparison of injectable forms of  hyaluronic acid and platelet rich fibrin in the treatment of interdental papillary loss. Type 1 and Type 2 papillary loss patients will be included and the clinical and photographic measurements  will be recorded at baseline and thereafter at 15 days, 1 month, 2 ,3 ,4 ,5 and 6 months post treatment and radiographic measurements will be recorded at baseline and after 6 months post treatment.

| |

| --- |

|

Detailed Description

Not available

Study Timeline

• Study Start: 2020-12-24
• Last Update Posted: 2020-12-30

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

•Patients in good general health •Patients with at least one Type I or II (Norland and Tarnow’s classification)7 deficient papilla in anterior region •Well aligned maxillary teeth, no spacing, no crowding or intrusion or extrusion.

Exclusion Criteria

• •Pregnant and lactating mothers •History of tobacco consumption.
• •History of taking any medications which are known to increase the risk of gingival hyperplasia.
• •Any artificial crown, proximal cervical restoration or abrasion of maxillary anterior teeth.
• •Any known allergy with hyaluronic acid •Patients with history of traumatic oral hygiene measures or periodontal surgeries over the last 6 months at the area of interest.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
2.Clinical measurement: distance from the contact point (CP) to papillary tip using the prepared stent	follow up at 15th day, 1, 2, 3,4,5,6 months and the clinical and photographic parameters will be re-recorded
b.Interdental width at the level of facial CEJ	follow up at 15th day, 1, 2, 3,4,5,6 months and the clinical and photographic parameters will be re-recorded
3.Photographic measurement:	follow up at 15th day, 1, 2, 3,4,5,6 months and the clinical and photographic parameters will be re-recorded
4.Radiographic measurement.	follow up at 15th day, 1, 2, 3,4,5,6 months and the clinical and photographic parameters will be re-recorded
The following distances will be measured	follow up at 15th day, 1, 2, 3,4,5,6 months and the clinical and photographic parameters will be re-recorded
a.Distance from CP to crest of the bone (BC)	follow up at 15th day, 1, 2, 3,4,5,6 months and the clinical and photographic parameters will be re-recorded

Secondary Outcome Measures

Name	Time	Method
1.A questionnaire for assessment of patient’s response including questions regarding patient’s assessment of black triangle	First day of treatment and after 6 months

Trial Locations

Locations (1)

Institute of Dental Studies and Technologies; 🇮🇳 Ghaziabad, UTTAR PRADESH, India

Institute of Dental Studies and Technologies

🇮🇳Ghaziabad, UTTAR PRADESH, India

Dr Aneesha Gupta

Principal investigator

8715014786

aneeshagupta03@gmail.com